- Home
- VRAX vs SGLY Comparison
VRAX vs SGLY Comparison
Compare VRAX & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- SGLY
- Stock Information
- Founded
- VRAX 2013
- SGLY 2001
- Country
- VRAX United Kingdom
- SGLY United States
- Employees
- VRAX N/A
- SGLY N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SGLY
- Sector
- VRAX Health Care
- SGLY
- Exchange
- VRAX Nasdaq
- SGLY Nasdaq
- Market Cap
- VRAX 4.7M
- SGLY 3.9M
- IPO Year
- VRAX 2022
- SGLY 2008
- Fundamental
- Price
- VRAX $0.81
- SGLY $1.03
- Analyst Decision
- VRAX Strong Buy
- SGLY
- Analyst Count
- VRAX 1
- SGLY 0
- Target Price
- VRAX $3.00
- SGLY N/A
- AVG Volume (30 Days)
- VRAX 37.2K
- SGLY 67.2K
- Earning Date
- VRAX 02-05-2025
- SGLY 08-26-2025
- Dividend Yield
- VRAX N/A
- SGLY N/A
- EPS Growth
- VRAX N/A
- SGLY N/A
- EPS
- VRAX N/A
- SGLY N/A
- Revenue
- VRAX $84,872.00
- SGLY $2,172,036.00
- Revenue This Year
- VRAX $5,169.18
- SGLY N/A
- Revenue Next Year
- VRAX $66.97
- SGLY N/A
- P/E Ratio
- VRAX N/A
- SGLY N/A
- Revenue Growth
- VRAX 7.03
- SGLY N/A
- 52 Week Low
- VRAX $0.75
- SGLY $0.54
- 52 Week High
- VRAX $9.00
- SGLY $7.65
- Technical
- Relative Strength Index (RSI)
- VRAX 31.75
- SGLY 51.57
- Support Level
- VRAX $0.75
- SGLY $1.02
- Resistance Level
- VRAX $0.85
- SGLY $1.16
- Average True Range (ATR)
- VRAX 0.07
- SGLY 0.08
- MACD
- VRAX -0.01
- SGLY -0.01
- Stochastic Oscillator
- VRAX 6.57
- SGLY 50.00
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.